Lensar Announces Q3 Earnings Per Share of 31 Cents Compared to 13 Cents Last Year
Reports Q3 revenue $14.3M vs. $13.5M last year. "We are pleased with the continued adoption of ALLY both in the U.S. and abroad, as well as the continuous, positive feedback from surgeons reinforcing ALLY's compelling value proposition," said Nick Curtis, President and CEO of LENSAR. "We grew the ALLY installed base significantly over the past 12 months and achieved solid growth in procedure volume compared to the third quarter of 2024. We continue to deliver increased value to our surgeon partners through higher efficiencies and excellent patient outcomes. In association with our pending acquisition by Alcon, we continue to work collaboratively with the U.S. Federal Trade Commission, responding to its request for additional information, and now expect the transaction to close in the first quarter of 2026."
